Lorus recruits first patient in anticancer drug Phase I trial
The Phase I study is expected to recruit 22-37 patients with advanced or metastatic solid tumors for which no effective therapy is currently available, or whose cancer has
Schrödinger has entered a strategic agreement with Bristol Myers Squibb (BMS) to integrate its AI-based co-scientist platform Bunsen into BMS’s research operations.
Calcitonin is a drug indicated for the treatment of postmenopausal osteoporosis, hypercalcemia, and Paget’s disease, and is commercially available in subcutaneous, intramuscular and nasal routes. The open-label, single-dose,